Macrophage M0
Cross-source consensus on Macrophage M0 from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Benefits
Highlighted claims
- The strongest validated signal was the M0 macrophage signature using the pan-cancer CIBERSORTx matrix and ensemble classifier. — Predictive radiomics for evaluation of cancer immune SignaturE in glioblastoma: the PRECISE-GBM study
- The M0 signature depended on distributed imaging features rather than a single dominant measurement. — Predictive radiomics for evaluation of cancer immune SignaturE in glioblastoma: the PRECISE-GBM study
- MRI appears to contain a radiomic phenotype associated with M0 macrophage abundance or status in the glioblastoma immune microenvironment. — Predictive radiomics for evaluation of cancer immune SignaturE in glioblastoma: the PRECISE-GBM study
- Predicted M0-high patients had longer overall survival than predicted M0-low patients in the study’s survival analysis. — Predictive radiomics for evaluation of cancer immune SignaturE in glioblastoma: the PRECISE-GBM study